ArticleFrontiers in immunology2021

Bispecific NKG2D-CD3 and NKG2D-CD16 Fusion Proteins as Novel Treatment Option in Advanced Soft Tissue Sarcomas.

Ilona Hagelstein et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.